Sartaj Hussain

Sartaj Hussain

Auto-generated profile, based on publicly available information

Sartaj Hussain

Department of Pharmacology and Therapeutics, King George’s Medical University,Lucknow, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
SYSuraj S. Yadav
Suraj S. Yadav
MSManish K. Singh
Manish K. Singh
SHSartaj Hussain
Sartaj Hussain
PDPradeep Dwivedi
Pradeep Dwivedi
SKSanjay Khattri
Sanjay Khattri
KSKuldeep Singh
Kuldeep Singh
Translation of traditional knowledge of herbs into a viable product for clinical use is still an uphill task. Piperine, a pungent alkaloid molecule derived from Piper nigrum and Piper longum possesses diverse pharmacological effects. Traditionally, pepper is used for arthritis, bronchitis, gastritis, diarrhea, snake bite, menstrual pain, fever, and bacterial infections, etc. The anti-inflammatory, antioxidant and immunomodulatory actions of piperine are the possible mechanisms behind its therapeutic potential. Various in-silico and experimental studies have shown piperine as a possible promising molecule in coronavirus disease (COVID-19), ebola, and dengue due to its immunomodulatory and antiviral activities. The other important clinical applications of piperine are due to its bio enhancing effect on drugs, by modulating, absorption in the gastrointestinal tract, altering activities of transporters like p-glycoprotein substrates, and modulating drug metabolism by altering the expression of cytochrome P450 or UDP-glucuronosyltransferase enzymes. Piperine attracted clinicians in treating patients with arthritis, metabolic syndrome, diabetes, skin infections, gastric and liver disorders. This review focused on systematic, evidence-based insight into the use of piperine in clinical settings and mechanistic details behind its therapeutic actions. Also, highlights a number of clinical trials of piperine at various stages exploring its clinical application in cancer, neurological, respiratory, and viral disease, etc.

26 July 2022 in Journal of Immunoassay and Immunochemistry
Verified
Journal Article
Closed access
SYSuraj Singh Yadav
Suraj Singh Yadav
SHSartaj Hussain
Sartaj Hussain
PDPradeep Dwivedi
Pradeep Dwivedi
SKSanjay Khattri
Sanjay Khattri
KSKamal Kumar Sawlani
Kamal Kumar Sawlani
KUKauser Usman
Kauser Usman
Our study focused on investigating the clinical significance of serum Sfrp5/Wnt-5a levels as a risk marker in metabolic syndrome (MetS). The study involved a total of 107 treatment-naive MetS cases and 100 controls with similar age and sex belonging to northern India. The profiling of clinical, biochemical, and anthropometric variables was done. ELISA methods were employed for serum cytokine estimation. Serum Sfrp5 was inversely correlated with BMI, WC, SBP, DBP, FPG, TG, fasting insulin level, and HOMA-IR in both males and females. The best cutoff value for Sfrp5 to predict MetS in males was ≤40.48 ng/ml (sensitivity 53.70% and specificity 90.48%), while in female, it was ≤66.67 ng/ml (sensitivity 98.11% and specificity 34.48%). MetS occurrence decreased with increasing concentration of Sfrp5 with an odds ratio (OR) of 0.95 (95% CI = 0.92–0.98, P < .001) in male and 0.93 (95% CI = 0.91–0.97, P < .001) in female. Quartile analysis revealed that odds of MetS significantly decreased in quartile 4 vs. 1, 0.06 (95% CI = 0.01–0.25), P = .001 and 0.13 (95% CI = 0.04–0.44), P = .001, respectively, in male and female. The inverse association of serum concentration of Sfrp5 with MetS might have a useful addition to the available risk marker as well as a therapeutic target for MetS.